Controlled Tissue Dissection Systems and Methods
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/IL2011/000018, filed Jan 6, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,201,325 | Controlled Tissue Dissection Systems and Methods In force · High confidence | Bioprotect Ltd. | In force | High confidence | ||
| US 11,918,414 | Controlled Tissue Dissection Systems and Methods In force · High confidence | Bioprotect Ltd. | In force | High confidence | ||
| Application 18/427,167 | Controlled Tissue Dissection Systems and Methods Pending Not granted | Bioprotect Ltd. | Pending | Not granted | ||
| Application 19/090,800 | Controlled Tissue Dissection Systems and Methods Abandoned Abandoned Nov 15, 2025 | Bioprotect Ltd. | Abandoned | Abandoned Nov 15, 2025 | ||
| Application 19/288,727 | Controlled Tissue Dissection Systems and Methods Pending Not granted | Bioprotect Ltd. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Bioprotect Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.